Patients with deadly TB released in South Africa22nd January 2014New tech offers hope of tackling TB in South Africa22nd March 2014 2 Professor Dheda receives the MRC Gold Merit Award Related postsTITLE: Efficacy and safety of a 4-month quabodepistat, delamanid, and bedaquiline regimen for drug-susceptible pulmonary tuberculosis: a multicentre, open-label, randomised, proof-of-concept, non-inferiority, phase 2b/c trialRead moreThe Order of Mapungubwe Honour Awarded to Prof K DhedaRead moreUnderstanding food allergies: symptoms, common triggers and how to manage themRead more